MLYS

NASDAQ · Biotechnology

Mineralys Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$28.02

+0.04 (+0.14%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +232.6% upside

Low Target $50.31

Average Target $93.19

High Target $121.15

Current Price $28.02

Current
$28.02

Target
$93.19

$50.31 $93.19 avg $121.15

Scenario Analysis

Bear Case

$50.31

79.6%

Low target

Base Case

$93.19

+232.6%

Avg target

Bull Case

$121.15

+332.4%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$47.65

-41.2% from high

52-Week Low

$22.30

+25.7% from low

50-Day SMA

$33.44

-16.2% vs SMA

200-Day SMA

$27.93

+0.3% vs SMA

RSI (14)

35.0

Neutral

Target vs 52W High

$93.19

+95.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.4%
AMGN Amgen Inc	Hold	43	47%	$190.87	-50.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-3.0%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%